Alpha 2-adrenergic sensitivity in Parkinson's disease.
Identifieur interne : 001706 ( PubMed/Checkpoint ); précédent : 001705; suivant : 001707Alpha 2-adrenergic sensitivity in Parkinson's disease.
Auteurs : M. Berlan [France] ; O. Rascol ; J. Belin ; J P Moatti ; A. Rascol ; J L MontastrucSource :
- Clinical neuropharmacology [ 0362-5664 ] ; 1989.
English descriptors
- KwdEn :
- Adult, Aged, Blood Glucose (analysis), Blood Pressure (drug effects), Clonidine (pharmacology), Fatty Acids, Nonesterified (blood), Female, Growth Hormone (blood), Heart Rate (drug effects), Humans, Insulin (blood), Male, Middle Aged, Parkinson Disease (blood), Parkinson Disease (physiopathology), Receptors, Adrenergic, alpha (physiology).
- MESH :
- chemical , analysis : Blood Glucose.
- chemical , blood : Fatty Acids, Nonesterified, Growth Hormone, Insulin.
- blood : Parkinson Disease.
- drug effects : Blood Pressure, Heart Rate.
- chemical , pharmacology : Clonidine.
- chemical , physiology : Receptors, Adrenergic, alpha.
- physiopathology : Parkinson Disease.
- Adult, Aged, Female, Humans, Male, Middle Aged.
PubMed: 2541904
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:2541904Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Alpha 2-adrenergic sensitivity in Parkinson's disease.</title>
<author><name sortKey="Berlan, M" sort="Berlan, M" uniqKey="Berlan M" first="M" last="Berlan">M. Berlan</name>
<affiliation wicri:level="3"><nlm:affiliation>Laboratoire de Pharmacologie Médicale et Clinique, INSERM U 317, CHU, Faculté de Médecine, Toulouse, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Pharmacologie Médicale et Clinique, INSERM U 317, CHU, Faculté de Médecine, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rascol, O" sort="Rascol, O" uniqKey="Rascol O" first="O" last="Rascol">O. Rascol</name>
</author>
<author><name sortKey="Belin, J" sort="Belin, J" uniqKey="Belin J" first="J" last="Belin">J. Belin</name>
</author>
<author><name sortKey="Moatti, J P" sort="Moatti, J P" uniqKey="Moatti J" first="J P" last="Moatti">J P Moatti</name>
</author>
<author><name sortKey="Rascol, A" sort="Rascol, A" uniqKey="Rascol A" first="A" last="Rascol">A. Rascol</name>
</author>
<author><name sortKey="Montastruc, J L" sort="Montastruc, J L" uniqKey="Montastruc J" first="J L" last="Montastruc">J L Montastruc</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1989">1989</date>
<idno type="RBID">pubmed:2541904</idno>
<idno type="pmid">2541904</idno>
<idno type="wicri:Area/PubMed/Corpus">001847</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001847</idno>
<idno type="wicri:Area/PubMed/Curation">001806</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001806</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001806</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001806</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Alpha 2-adrenergic sensitivity in Parkinson's disease.</title>
<author><name sortKey="Berlan, M" sort="Berlan, M" uniqKey="Berlan M" first="M" last="Berlan">M. Berlan</name>
<affiliation wicri:level="3"><nlm:affiliation>Laboratoire de Pharmacologie Médicale et Clinique, INSERM U 317, CHU, Faculté de Médecine, Toulouse, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Pharmacologie Médicale et Clinique, INSERM U 317, CHU, Faculté de Médecine, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rascol, O" sort="Rascol, O" uniqKey="Rascol O" first="O" last="Rascol">O. Rascol</name>
</author>
<author><name sortKey="Belin, J" sort="Belin, J" uniqKey="Belin J" first="J" last="Belin">J. Belin</name>
</author>
<author><name sortKey="Moatti, J P" sort="Moatti, J P" uniqKey="Moatti J" first="J P" last="Moatti">J P Moatti</name>
</author>
<author><name sortKey="Rascol, A" sort="Rascol, A" uniqKey="Rascol A" first="A" last="Rascol">A. Rascol</name>
</author>
<author><name sortKey="Montastruc, J L" sort="Montastruc, J L" uniqKey="Montastruc J" first="J L" last="Montastruc">J L Montastruc</name>
</author>
</analytic>
<series><title level="j">Clinical neuropharmacology</title>
<idno type="ISSN">0362-5664</idno>
<imprint><date when="1989" type="published">1989</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Blood Glucose (analysis)</term>
<term>Blood Pressure (drug effects)</term>
<term>Clonidine (pharmacology)</term>
<term>Fatty Acids, Nonesterified (blood)</term>
<term>Female</term>
<term>Growth Hormone (blood)</term>
<term>Heart Rate (drug effects)</term>
<term>Humans</term>
<term>Insulin (blood)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Parkinson Disease (blood)</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Receptors, Adrenergic, alpha (physiology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Blood Glucose</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Fatty Acids, Nonesterified</term>
<term>Growth Hormone</term>
<term>Insulin</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Blood Pressure</term>
<term>Heart Rate</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Clonidine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en"><term>Receptors, Adrenergic, alpha</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">2541904</PMID>
<DateCreated><Year>1989</Year>
<Month>07</Month>
<Day>13</Day>
</DateCreated>
<DateCompleted><Year>1989</Year>
<Month>07</Month>
<Day>13</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0362-5664</ISSN>
<JournalIssue CitedMedium="Print"><Volume>12</Volume>
<Issue>2</Issue>
<PubDate><Year>1989</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Clinical neuropharmacology</Title>
<ISOAbbreviation>Clin Neuropharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Alpha 2-adrenergic sensitivity in Parkinson's disease.</ArticleTitle>
<Pagination><MedlinePgn>138-44</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Berlan</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Laboratoire de Pharmacologie Médicale et Clinique, INSERM U 317, CHU, Faculté de Médecine, Toulouse, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Rascol</LastName>
<ForeName>O</ForeName>
<Initials>O</Initials>
</Author>
<Author ValidYN="Y"><LastName>Belin</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Moatti</LastName>
<ForeName>J P</ForeName>
<Initials>JP</Initials>
</Author>
<Author ValidYN="Y"><LastName>Rascol</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Montastruc</LastName>
<ForeName>J L</ForeName>
<Initials>JL</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Clin Neuropharmacol</MedlineTA>
<NlmUniqueID>7607910</NlmUniqueID>
<ISSNLinking>0362-5664</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005230">Fatty Acids, Nonesterified</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007328">Insulin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011942">Receptors, Adrenergic, alpha</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>9002-72-6</RegistryNumber>
<NameOfSubstance UI="D013006">Growth Hormone</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>MN3L5RMN02</RegistryNumber>
<NameOfSubstance UI="D003000">Clonidine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003000" MajorTopicYN="N">Clonidine</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005230" MajorTopicYN="N">Fatty Acids, Nonesterified</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013006" MajorTopicYN="N">Growth Hormone</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011942" MajorTopicYN="N">Receptors, Adrenergic, alpha</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1989</Year>
<Month>4</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1989</Year>
<Month>4</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1989</Year>
<Month>4</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">2541904</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>France</li>
</country>
<region><li>Midi-Pyrénées</li>
<li>Occitanie (région administrative)</li>
</region>
<settlement><li>Toulouse</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Belin, J" sort="Belin, J" uniqKey="Belin J" first="J" last="Belin">J. Belin</name>
<name sortKey="Moatti, J P" sort="Moatti, J P" uniqKey="Moatti J" first="J P" last="Moatti">J P Moatti</name>
<name sortKey="Montastruc, J L" sort="Montastruc, J L" uniqKey="Montastruc J" first="J L" last="Montastruc">J L Montastruc</name>
<name sortKey="Rascol, A" sort="Rascol, A" uniqKey="Rascol A" first="A" last="Rascol">A. Rascol</name>
<name sortKey="Rascol, O" sort="Rascol, O" uniqKey="Rascol O" first="O" last="Rascol">O. Rascol</name>
</noCountry>
<country name="France"><region name="Occitanie (région administrative)"><name sortKey="Berlan, M" sort="Berlan, M" uniqKey="Berlan M" first="M" last="Berlan">M. Berlan</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001706 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001706 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:2541904 |texte= Alpha 2-adrenergic sensitivity in Parkinson's disease. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:2541904" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a ParkinsonFranceV1
![]() | This area was generated with Dilib version V0.6.29. | ![]() |